Myasthenia gravis is an autoimmune disease in which the body's immune system mistakenly produces autoantibodies that bind to and block acetylcholine receptors at the neuromuscular junction, leading to progressive muscle weakness.
Which of the following therapeutic strategies would be an effective treatment to alleviate the symptoms of Myasthenia gravis?
Therapeutic administration of monoclonal antibodies that specifically target and neutralize the autoantibodies.
Vaccination with purified acetylcholine receptor proteins to promote active immunity.
Prescribing a course of broad-spectrum antibiotics to target the site of neuromuscular damage.
Administration of cytokines to promote the differentiation of B-lymphocytes into plasma cells.